Scientists Create a “Periodic Table” for Artificial Intelligence

Researchers have proposed a unifying mathematical framework that helps explain why many successful multimodal AI systems work ...
Business Wire

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Business Wire

Variational AI Announces Generative AI Project With Merck

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...
Hosted on MSN

Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development

Merck & Co. Inc., (NYSE:MRK) is one of the best conservative stocks to buy now. On September 23, the company confirmed a strategic collaboration with Variational AI to leverage its Enki Platform in ...
FierceBiotech

Merck inks $349M biobucks deal to apply AI to challenging targets

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
pharmaphorum

MSD's $345m alliance with Variational, and other AI news

MSD has signed an agreement with Variational AI to use its generative AI (genAI) platform Enki in the discovery of new small-molecule medicines. Vancouver, Canada-based Variational – which emerged in ...
Vancouver

B.C. AI venture Variational AI partners with Merck

Variational AI CEO Handol Kim's company has a platform that uses the language of chemistry to create drug recipes | Rob Kruyt Multinational drug developer Merck is partnering with a Vancouver-based ...